Protective specific immunity induced by doxorubicin plus TNF-alpha combination treatment of EL4 lymphoma-bearing C57BL/6 mice.

Protective specific immunity induced by doxorubicin plus TNF-alpha combination treatment of EL4 lymphoma-bearing C57BL/6 mice. Int J Cancer. 2000 Jul 01; 87(1):101-9.

View in: PubMed

subject areas

Age Factors
Animals
Antineoplastic Combined Chemotherapy Protocols
Cell Survival
Cells, Cultured
Doxorubicin
Female
Humans
Immunity, Cellular
Immunologic Memory
Killer Cells, Lymphokine-Activated
Kinetics
Lymphoma
Mice
Mice, Inbred C57BL
Recombinant Proteins
Spleen
Thymus Gland
Time Factors
Tumor Cells, Cultured
Tumor Necrosis Factor-alpha

authors with profiles

SRDAN VERSTOVSEK